HomeLUPIN • NSE
add
Lupin Ltd
Nakaraang pagsara
₹2,357.30
Sakop ng araw
₹2,297.20 - ₹2,361.90
Sakop ng taon
₹1,795.20 - ₹2,377.60
Market cap
1.06T INR
Average na Volume
900.42K
P/E ratio
21.18
Dividend yield
0.52%
Primary exchange
NSE
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (INR) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 71.68B | 24.27% |
Gastos sa pagpapatakbo | 33.93B | 18.38% |
Net na kita | 11.76B | 37.47% |
Net profit margin | 16.40 | 10.59% |
Kita sa bawat share | 32.18 | 72.18% |
EBITDA | 21.20B | 52.17% |
Aktuwal na % ng binabayarang buwis | 22.44% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (INR) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 62.82B | 115.71% |
Kabuuang asset | — | — |
Kabuuang sagutin | — | — |
Kabuuang equity | 197.28B | — |
Natitirang share | 456.70M | — |
Presyo para makapag-book | 5.48 | — |
Return on assets | — | — |
Return on capital | 18.27% | — |
Cash Flow
Net change in cash
| (INR) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 11.76B | 37.47% |
Cash mula sa mga operasyon | — | — |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | — | — |
Net change in cash | — | — |
Malayang cash flow | — | — |
Tungkol
Lupin Limited is an Indian multinational pharmaceutical company based in Mumbai. It is primarily a manufacturer of generic drugs, covering therapeutic areas such as paediatrics, cardiovascular, anti-infectives, diabetology, asthma and anti-tuberculosis.The company operates in multiple international markets including the United States, Japan, Europe, and Australia.. Wikipedia
Itinatag
1968
Headquarters
Website
Mga Empleyado
24,006
